Skip to content
Methodology
All entries for: Xylyx Bio
September 18, 2025
Xylyx Bio
Orphan Drug Designation
FDA orphan drug designation: treatment of lung failure requiring lung transplantation
Disease Area:
Rare Diseases
Source
Scroll to Top
